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Introduction: Cell therapy using adipose-derived stem cells has been reported to improve chronic wounds via
differentiation and paracrine effects. One such strategy is to deliver stem cells in hydrogels, which are studied
increasingly as cell delivery vehicles for therapeutic healing and inducing tissue regeneration. This study aimed to
determine the behaviour of encapsulated adipose-derived stem cells and identify the secretion profile of suitable
growth factors for wound healing in a newly developed thermoresponsive PEG–hyaluronic acid (HA) hybrid
hydrogel to provide a novel living dressing system.
Methods: In this study, human adipose-derived stem cells (hADSCs) were encapsulated in situ in a water-soluble,
thermoresponsive hyperbranched PEG-based copolymer (PEGMEMA–MEO2MA–PEGDA) with multiple acrylate
functional groups in combination with thiolated HA, which was developed via deactivated enhanced atom transfer
radical polymerisation of poly(ethylene glycol) methyl ether methacrylate (PEGMEMA, Mn = 475), 2-(2-methoxyethoxy)
ethyl methacrylate (MEO2MA) and poly(ethylene glycol) diacrylate PEGDA (Mn = 258). hADSCs embedded in the
PEGMEMA–MEO2MA–PEGDA and HA hybrid hydrogel system (P-SH-HA) were monitored and analysed for their cell
viability, cell proliferation and secretion of growth factors (vascular endothelial growth factor, transforming growth
factor beta and placental-derived growth factor) and cytokines (IFNγ, IL-2 and IL-10) under three-dimensional culture
conditions via the ATP activity assay, alamarBlueW assay, LIVE/DEADW assay and multiplex ELISA, respectively.
Results: hADSCs were successfully encapsulated in situ with high cell viability for up to 7 days in hydrogels. Although
cellular proliferation was inhibited, cellular secretion of growth factors such as vascular endothelial growth factor and
placental-derived growth factor production increased over 7 days, whereas IL-2 and IFNγ release were unaffected.
Conclusion: This study indicates that hADSCs can be maintained in a P-SH-HA hydrogel, and secrete pro-angiogenic
growth factors with low cytotoxicity. With the potential to add more functionality for further structural modifications,
this stem cell hydrogel system can be an ideal living dressing system for wound healing applications.
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Chronic wound healing has remained difficult despite
the advances in tissue engineering such as bioengineered
skin substitutes [1]. At least 50% of chronic wounds
remain resistant to advanced or standard treatments such
as growth factor delivery or bioengineered skin substi-
tutes [2]. In recent years, stem cell-based therapies have
emerged as therapeutic alternatives in the regeneration
and repair of damaged organs and tissues for various
diseases [3]. Recent studies in delayed wound healing
animal models using stem cells have been encouraging
in treating of chronic wounds [4,5]. Among the many
factors contributing to impaired wound healing, the
main factors are the reduction of cytokines and reduced
neovascularisation [6,7]. Bone marrow-derived stem cells
have been shown to modulate the immune response and
provide the building blocks for the regeneration of wounds
in recent studies [8,9]. Furthermore, adipose-derived stem
cells have shown multipotency and secrete many growth
factors such as insulin-like growth factor, hepatocyte
growth factor, transforming growth factor beta 1 (TGF-β1)
and vascular endothelial growth factor (VEGF) that are
essential in wound healing and have been shown to
heal chronic wounds in preclinical wound healing
models [10-13]. In a recent study, human adipose-derived
stem cells (hADSCs) embedded in a collagen hydrogel
secreted increased levels of growth factors to enhance
wound healing [14].
The main strategy to deliver stem cells or growth
factors to chronic wounds involves direct injection to the
injury site. However, this method leads to poor engraft-
ment and poor efficacy due to proteolytic degradation
within the first few hours post injection, thus preventing
the beneficial effects of these expensive biological agents
[15,16]. These problems can be overcome with the use of
a delivery scaffold of natural or synthetic origin. Hydrogel
scaffolds have recently been extensively studied because
their hydrophilic and injectable properties make them a
suitable delivery system for drugs and stem cell therapy
[17-21]. Hydrogels can encapsulate stem cells and main-
tain good viability while keeping their phenotype, which
can provide a three-dimensional (3D) microenvironment
for stem cells to closely mimic the in vivo conditions lead-
ing to stimulation of cellular proliferation, differentiation
and regeneration via physical or chemical cues [22-24].
However, most of these hydrogel systems are developed via
UV crosslinking or require multistep chemically modified
reactions and purification methods, which causes safety
concerns and increased cost as well as requiring complex
preparation methods [25,26].
A PEG-based thermoresponsive hyperbranched copoly-
mer of poly(ethylene glycol) methyl ether methacrylate-co-
2-(2-methoxyethoxy) ethyl methacrylate-co-poly(ethylene
glycol) diacrylate (PEGMEMA475–MEO2MA–PEGDA258)was developed recently using a one-pot and one-step
deactivated enhanced atom transfer radical polymerisation
method in our group [27]. This copolymer exhibited a
lower critical solution temperature that was close to body
temperature. Once the polymer solution was applied at
body temperature, a thermal gelation rapidly occurred.
In addition, with high content of vinyl functional
groups, this polymer further crosslinks chemically with
thiolated hyaluronan (HA-SH) in minutes via a Michael-
type thiolene reaction, which increases the mechanical
properties of the hydrogel. This thermoresponsive hydro-
gel system allows in situ encapsulation of stem cells in a
very short period of time, which can be used to deliver
cells and growth factors. The secretion of growth factors
from embedded cells could help induce the healing
process in chronic wounds (Figure 1C).
The purpose of this study is to analyse this system
for soft-tissue engineering by successful encapsulation
of hADSCs in situ. The effects of the PEGMEMA–
MEO2MA–PEGDA and HA hybrid (P-SH-HA) hydrogel
on cellular toxicity, proliferation and secretion of
proinflammatory/anti-inflammatory and angiogenic growth
factors were examined. Herein, we describe the preliminary
characterisation of P-SH-HA synthetic extracellular matrix




The chemicals PEGMEMA (Mn = 475 g/mol), MEO2MA,
and PEGDA (Mn = 258 g/mol) were purchased from
Sigma-Aldrich (Wicklow, Ireland). HA-SH (HyStem™,
Glycosan) was purchased from BioTime Inc. (Alameda,
CA, USA). All chemicals were of analytical grade.
PEGMEMA–MEO2MA–PEGDA polymer synthesis and
characterisation
The PEGMEMA–MEO2MA–PEGDA copolymer was
synthesised by the copolymerising of PEGMEMA,
MEO2MA and PEGDA via an in situ deactivation-enhanced
atom transfer radical polymerisation approach as previously
described [28]. Briefly, PEGMEMA (7.4 g, 0.015 moles),
MEO2MA (12.8 g, 0.068 moles), PEGDA (5.4 g, 0.021
moles), the initiator ethyl 2-bromoisobutyrate (155 μl, 0.001
moles), copper(II) chloride (0.032 g, 0.0002 moles), bis(2-
dimethylaminoethyl)methylamine (64 μl, 0.0002 moles)
were added to a two-neck flask in 25 ml solvent butanone.
The mixture was stirred for complete dissolution followed
by purging with argon for 30 minutes to remove dissolved
oxygen. L-Ascorbic acid (0.011 g) was added to the poly-
merisation solution under argon conditions and the mixture
was heated in an oil bath to 50°C and stirred for 6 hours.
The polymerisation was stopped by opening the flask
and exposing the catalyst to air. After the polymerisation,
Figure 1 Schematic illustration of PEGMEMA475–MEO2MA–PEGDA258 copolymer synthesis and cross-linking with thiol-modified
hyaluronic acid. (A) Synthesis route via deactivation-enhanced atom transfer radical polymerisation (ATRP) at 60°C. (B) Cross-linking of
PEGMEMA–MEO2MA–PEGDA and HA hybrid (P-SH-HA) polymer with thiol-modified hyaluronic acid via Michael-type addition reaction showing
encapsulation of human adipose-derived stem cells (hADSCs) in the P-SH-HA hydrogel at 37°C. (C) Cartoon picture: application of P-SH-HA
hydrogel on a skin wound. The hADSCs are embedded in situ with P-SH-HA hydrogel and applied on the wound, which secrete growth factors
to accelerate wound healing. EGF, epidermal growth factor; FGF, fibroblast growth factor; PDGF, platelet-derived growth factor; TGF-β,
transforming growth factor beta; VEGF, vascular endothelial growth factor.
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tated into a large excess of diethyl ether and hexane (1:1.2)
to remove solvent and monomers. The precipitated
mixture of the polymer was dissolved in deionised water
and purified by dialysis (spectrum dialysis membrane, mo-
lecular weight cutoff 6,000 to 8,000) for 72 hours in a dark
environment at 4°C against fresh deionised water, while
the water was changed regularly. The pure polymer sam-
ples were obtained after freeze drying. The molecular
weight and molecular weight distributions were determined
for PEGMEMA–MEO2MA–PEGDA using gel permeation
chromatography (Polymer Laboratories) (Amherst, MA,
USA) with an (Refractive Index) detector using dime-
thylformamide as an eluent. The columns (30 cm PLgel
Mixed-C, two in series) were calibrated with poly (methylmethacrylate) standards. All calibrations and analysis were
performed at 60°C and a flow rate of 1 ml/minute. 1H-
NMR was carried out for PEGMEMA–MEO2MA–PEGDA
on a 300 MHz Bruker NMR with MestReC processing soft-
ware. The chemical shifts were referenced to the lock
chloroform (CDCl3) for PEGMEMA–MEO2MA–PEGDA
(Sigma, Wicklow, Ireland).
Hydrogel preparation
Commercially available HA-SH (Glycosan-HyStem™;
BioTime Inc.) was used for making hydrogels,. The
hydrogel was prepared by reacting the vinyl groups on the
hyperbranched copolymer with free thiol contents of HA-
SH at physiological condition via Michael-type addition.
For this purpose, HA-SH (1% w/v) and PEGMEMA–
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(pH 7.4) in separate glass vials. The two solutions were
combined in a volume ratio of 1:1 and gently mixed for 30
seconds. The solution was than incubated at 37°C to obtain
gels for further analysis.
Cell culture
STEMPROW hADSCs (Invitrogen) (Life Technologies,
Dublin, Ireland) isolated from human adipose tissue col-
lected during liposuction procedures were obtained at
passage 1. The cells were grown and passaged using
MesenPRO RS™ Medium (includes basal medium and
growth supplement; Invitrogen) during all of the studies
and used between passages 2 and 4. These cells have been
shown to express a cell-surface protein profile that is
positive for CD29, CD44, CD73, CD90, CD105, and
CD166 (>95%), and is negative for CD14, CD31, CD45,
and Lin1 (<2%).
Two-dimensional and three-dimensional cell culture
For two-dimensional (2D) culture, hADSCs were seeded
on a 96-well plate (2D) at a final concentration of 0.5×106
cells/ml. Similarly, for 3D culture the cell suspension was
mixed with PEGMEMA–MEO2MA–PEGDA and HA-SH
at a final concentration of 0.5×106 cells/ml. After gelation,
the cell laden gel constructs were transferred to a 48-well
plate and 0.5 ml MesenPRO RS™ media were added
supplemented with 2% growth supplement (Invitrogen).
The media was changed every second day. Tissue culture
plastic (TCP) seeded cells were used as experimental con-
trols in all experiments.
Cell viability
The alamarBlueW (Invitrogen) assay was performed to
evaluate the metabolic activity of hADSCs in the 3D cell
culture system. hADSCs were encapsulated in 3D
hydrogels as described above. At each time point, cells
were washed three times with PBS at 37°C, following
which 10% alamarBlueW in MesenPRO RS™ cell culture
media was added to the wells containing hydrogel con-
structs to assess the cell metabolic activity after 1, 3, 5
and 7 days. Viability of encapsulated cells was also mea-
sured via intracellular ATP activity using Celltiter-GloW
reagent (Promega) (Madison, WI, USA) at days 2, 5 and
7. Media from cell-laden hydrogels were removed and
replaced with 200 μl of 50% Celltiter-GloW reagent in
MesenPRO RS™ media. Following incubation on a
shaker for 45 minutes at room temperature, 150 μl of
the solutions were transferred into a 96-well white plate
for luminescence quantification using a microplate
reader. The LIVE/DEADW assay (Molecular Probes) (Life
Technologies, Dublin, Ireland) was also used to visualise
the distribution of living and dead cells in the hydrogel
at different time points for the 3D culture system.Fluorescence images were taken using an Olympus
Fluoview Confocal Microscope.
Cell proliferation assay
Cell proliferation was determined using PicoGreenW
fluorescent DNA quantification (Molecular Probes) kit
at days 2 and 7 for both 3D and 2D culture as described
by the manufacturer. DNA from cell-laden hydrogels
was recovered by first mechanically digesting hydrogels
and then enzymatically in proteinase K overnight at
56°C. Briefly, 100 μl DNA samples were incubated with
100 μl diluted (1:200) PicoGreenW reagent in 1× TE buf-
fer in a 96-well opaque, flat-bottomed assay plate. The
fluorescence was read at excitation 485 nm and emission
525 nm and was compared with a DNA standard curve
provided with the kit.
Determination of growth factor secretion
After each predetermined time point (days 1, 3, 5 and 7),
conditioned media from both 2D and 3D culture systems
was collected and stored at −80°C for later analysis of the
secreted factors using a multiplex ELISA system. The
media was not changed in these samples until 7 days. The
cell-laden hydrogels (3D) and cells on TCP (2D) were also
harvested and stored at −80°C until further analysis. The
conditioned media of hADSCs were analysed (days 1, 3, 5
and 7) for both the angiogenic growth factors VEGF,
placental-derived growth factor (PlGF), TGF-β and the
proinflammatory/anti-inflammatory cytokines IFNγ, IL-2
and IL-10 by the Mesoscale development system with
multiplex ELISA kits (MSD TH1/TH2 7-plex, MSD
Human Growth factor 1 4-Plex) (Meso Scale Discovery,
Gaithersburg, MD, USA) as described by the manufacturer.
Statistical analysis
All data are expressed as mean ± standard deviation of
triplicate samples. Comparisons between multiple groups
were performed using one-way ANOVA. All analyses were
performed with GraphPad Prism 5 (CA, USA). Differences
between two datasets were considered significant when
P <0.05.
Results and discussion
3D culture systems have frequently been used to mimic
in vivo conditions. These systems allow for the control of
cellular behaviour by providing control over properties of
material substrates and microenvironments using natural
or synthetic materials. This control allows creation of a
stem cell niche to maintain or control the stemness of
cells. Many synthetic and biological 3D systems such as
collagen, hyaluronic acid, PEG-based synthetic extracellu-
lar matrix (QGEL™ ) (Lausanne, Switzerland) and chito-
san have been reported recently [24]. However, most of
these systems are synthesised via chemical modifications,
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methods leading to increased production costs as well as
giving rise to complex preparation methods. To overcome
these problems, a hyperbranched PEG-based copolymer
was therefore recently synthesised using a one-pot and
one-step synthesis method (Figure 1A). This synthesis cre-
ates a hydrogel with thermoresponsive properties and de-
sired end functionality to provide an in situ crosslinking
system that can crosslink with HA-SH via Michael-type
addition (Figure 1B). This hydrogel system allows encapsu-
lation of stem cells in situ, which could potentially be used
as a system to form a dressing upon application for
wound repairs (Figure 1C). Understanding stem cell
behaviour and analysing the ability for cells to secrete
growth factors is therefore essential. In this paper,
PEG-based thermoresponsive copolymer cross-linked with
HA-SH was studied for hADSC viability, proliferation and
secretion of pro-angiogenic growth factors and inflamma-
tory cytokines under 3D culture condition. Cells seeded
on TCP (2D) were used throughout the experiments to
provide experimental control for the secretion of growth
factors, proliferation of cells and viability.
PEGMEMA–MEO2MA–PEGDA polymer synthesis and
characterisation
Synthesis and characterisation of the PEGMEMA–
MEO2MA–PEGDA copolymer was carried out as previ-
ously reported [28]. The reaction for the polymer was
stopped when the desired molecular weight (70 kDa) was
reached. The hyperbranched structure of the polymer was
confirmed by 1H-NMR and peaks at chemical shift of 6.4
to 5.8 ppm proved the presence of a vinyl functional group
as described previously [28].
Cell morphology in P-SH-HA hydrogel
Cellular morphology is an important phenomenon that
is correlated with important biochemical functions in-
volved in new tissue formation such as proliferation and
migration of cells. It is known that cells encapsulated in
PEG-based hydrogels without any attachment sites adopt
rounded morphology unless some extracellular matrix
materials are present [29]. The cell morphology for
hADSCs was therefore evaluated within the hydrogels
(3D) after encapsulation. It was noted the hADSCs were
stretched with spindle-like shape on 2D culture as
expected. In contrast, the cells in hydrogels lost this
morphology and showed more rounded, isolated distribu-
tion throughout the gel (Figure 2). The spreading, migra-
tion and attachment of cells in the 3D microenvironment is
dependent on many different factors; mainly substrate
density, stiffness, elastic modulus, degradation and adhesion
within the microenvironment of the hydrogels. Cells seeded
on HA hydrogels have been shown to spread via CD44 and
its co-receptor RHAMM [30]. In other studies, however,encapsulated cells in HA hydrogels do not spread but
maintain good viability [30,31]. Our results agree with the
latter studies, suggesting that hADSCs can remain viable in
P-SH-HA copolymer without spreading. This could be due
to the lack of presentation of attachment sites and recep-
tors because of the highly cross-linked network.
Cellular viability in P-SH-HA hydrogel
To evaluate the biocompatibility of the hydrogels with
hADSCs, quantitative cellular metabolic activity and via-
bility were assessed using the alamarBlueW assay and the
ATP assay, respectively. Qualitative analysis was carried
out via the LIVE/DEADW assay. hADSCs were encapsu-
lated in hydrogel scaffold at a final concentration of
0.5×106 cells/ml for up to 7 days. Unseeded hydrogels
alone were used as negative control and tissue culture
plastic (2D) seeded hADSCs were used as positive experi-
mental controls. The alamarBlueW assay was utilised to
test the viability of encapsulated cells at each time point. It
was noted that after day 7 (49%), cellular activity remained
stable in comparison with day 1 (47%). This indicates that
there was no cytotoxic effect on cell metabolic activity
from the hydrogel system (Figure 3A). Similar results were
shown by ATP intracellular activity, which remained
above 82% for 7 days (Figure 3B).
The LIVE/DEADW assay (Molecular Probes) was
employed to visualise the distribution of living and dead
cells after 2, 5 and 7 days in the 3D cell culture system
(Figure 4). Calcein AM fluoresces green upon the reaction
of intracellular esterase and stains live cells; ethidium
homodimer-1, which binds to the DNA of dead membrane
compromised cells, stains dead cells (red). Few dead cells
appeared after 5 days; however, the number of live cells was
obviously much higher even after 7 days. We assumed that
the hydrogel density that was increased further by thermal
gelation in addition to chemical gelation and the
nondegradable property of the hydrogel have limited
the living space for the encapsulated cells and that the
exchange of nutrients may not have been efficient and
could have caused a slight drop in cell viability after 7
days. Overall, one can conclude that this nontoxic in situ
gelling system can provide a suitable microenvironment in
which hADSCs remain viable for up to 7 days.
Cellular proliferation in P-SH-HA hydrogel
The cell-encapsulated hydrogel samples prepared as
mentioned above were digested mechanically and enzy-
matically with proteinase K prior to analysis. The DNA
content was recovered and analysed with PicoGreenW
assay after day 2 and day 7. The concentration of DNA
from encapsulated cells was maintained at similar levels
across both time periods; that is, 82.12 ± 19.20 ng/ml at
day 2 and 90.15 ± 3.80 ng/ml at day 7 (Figure 5). The
proliferation rate from 3D seeded cells was significantly
Figure 2 Phase images of tissue culture plastic and hydrogel encapsulated human adipose-derived stem cells. Phase image of tissue
culture plastic (TCP; two-dimensional) and hydrogel (three-dimensional) encapsulated human adipose-derived stem cells (hADSCs) exhibiting (A)
fibroblastic-like morphology and (B) rounded morphology after 2 days of seeding. hADSCs were seeded at a final concentration of 0.5×106 cells/ml in
a 96-well plate.
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has been reported elsewhere and might be attributable
to the cellular microenvironment [32]. These results in-
dicate that the hADSCs did not proliferate in hydrogel
even after 7 days. For spreading and migration of cell inFigure 3 Cellular metabolic activity and viability of encapsulated hum
(Invitrogen ) (Life Technologies, Dublin, Ireland) for encapsulated human ad
HA hybrid hydrogels at days 2, 5 and 7 (mean ± standard deviation, n = 3)
indicated time after encapsulation and was used to represent cell metabol
luminescence units.a 3D structure, they need to be able to degrade the poly-
meric structure or extracellular matrix. HA is a degradable
molecule; however, when cross-linked with a PEG-based
polymer it can become difficult for cells to degrade. Cells
secreting hyaluronidase can degrade the P-SH-HAan adipose-derived stem cells. (A) The alamarBlueW metabolic assay
ipose-derived stem cells (hADSCs) in PEGMEMA–MEO2MA–PEGDA and
. (B) Intracellular activity of ATP of hADSCs was measured at the
ic activity and viability (mean ± standard deviation, n = 3). RLU, relative
Figure 4 Cellular viability with the LIVE/DEADW cell viability assay. Representative confocal Z-stack (300 μm) images of encapsulated human
adipose-derived stem cells stained with calcein AM (live) and ethidum homodimer (dead) viability staining kit at days 2, 5 and 7 using the LIVE/DEADW
assay (Molecular Probes) (Life Technologies, Dublin, Ireland). Live cells were stained green while dead cells were stained red. Scale bar: 100 μm.
Figure 5 Proliferation rates of human adipose-derived stem cells
in three-dimensional and two-dimensional cell culture conditions.
Cells were seeded at 0.5×106/ml. Cellular proliferation was determined
by PicoGreenW assay (Molecular Probes) (Life Technologies, Dublin,
Ireland) after recovering the DNA from cells in both three-dimensional
(3D) and two-dimensional (2D) culture systems. There was no
significant difference in cell proliferation rates in both 3D and 2D
cultures (n = 3, P <0.05).
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create enough space for cells to move around and prolif-
erate. Our results here agree with other reports
suggesting that nondegradable HA hydrogels suppress
proliferation of mammalian cells, but can maintain
viability [32].
Secretion analysis of angiogenic and inflammatory
cytokines
Growth factors and cytokines are important mediators
that allow cell–cell communication between other cell
types that have been shown to play important roles in
normal physiological and pathological processes. For
example, proinflammatory cytokines are mainly involved
in early stages of wound healing via inflammatory cells
and if not properly regulated can lead to abnormal
wound healing. In response to different materials, cells
can react and produce inflammatory cytokines. Analysing
the cellular response to newly developed biomaterials is
therefore necessary. For this purpose we selected IL-2 and
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to detrimental effects if not controlled properly.
From our results, the inflammatory cytokines analysed
were interestingly reduced from 28.38 ± 5.14 ng/ml at
day 1 to 7.38 ± 1.60 at day 7 ng/ml for IFNγ (Figure 6)
and from 2.73 ± 1.52 ng/ml at day 1 to 0.82 ± 0.21
ng/ml at day 7 for IL-2 in the 3D microenvironment
(Figure 6). Media from cells seeded on TCP were used
to analyse the 2D and 3D conditions for all time-points.
TCP seeded cells acted as positive controls to measure
cytokines and growth factors for ELISA because
hADSCs have shown to secrete a detectable amount of
growth factor in 2D conditions. There was no significant
difference in secretion of IFNγ and IL-2 at any time point
for TCP seeded cells. This indicated that the P-SH-HA
hydrogel scaffold did not induce an inflammatory response
and that the hydrogel is a suitable scaffold system for cell
encapsulation. For IL-10, an anti-inflammatory cytokine
that has been reported to be beneficial in dampening down
the immune response and can aid in impaired wound
healing, no significant difference was observed in both 3D
and 2D culture. However, it was noted that levels of IL-10
started to drop after day 3 in 2D culture but remained atFigure 6 Secretion profile for cytokines of human adipose-derived stem
profile of cytokines of human adipose-derived stem cells in both PEGMEMA–ME
culture plastic (two-dimensional (2D)) over 7 days. Cells were seeded at 0.5×106
supernatant from both conditions was analysed using a multiplex ELISA kit for Istable levels in 3D culture over 7 days (4.60 ± 1.07 ng/ml),
which may provide an indication that presence of HA in
the hydrogel scaffold can modulate an anti-inflammatory
response from the encapsulated cells. The secretion analysis
suggests that the hydrogel scaffold developed here does
not induce an inflammatory reaction from the encap-
sulated cells and that maintaining levels of IL-10 an
anti-inflammatory cytokine may be beneficial for appli-
cations in wound healing.
Hydrogel systems have been recently used to deliver
growth factors such as VEGF, keratinocyte growth factor,
basic fibroblast fibroblast growth factor and hepatocyte
growth factor for enhancing the wound healing process
[33-35]. This delivery does not translate well in clinical
settings, however, as is the case with becaplermin that
consists of platelet-derived growth factor [36]; adminis-
tering single growth factor to enhance angiogenesis in
atherosclerotic patients has also shown little success
[37]. During wound healing, multiple growth factors are
known to work in synergistic fashion to provide a posi-
tive outcome [38]. The secretion of anti-apoptotic and
angiogenic growth factors from stem cells can therefore
provide a valuable tool for angiogenic therapies. Incells in three-dimensional and two-dimensional cell culture. Secretion
O2MA–PEGDA and HA hybrid hydrogel (three-dimensional (3D)) and tissue
cells/ml in both 3D and 2D culture conditions in 48-well plates. The
L-2, IL-10 and IFNγ (n = 3, P <0.05).
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wound healing effectively by both directly differentiating
or providing necessary growth factors and cytokines at
local sites by enhancing angiogenic response [10]. These
beneficial effects of hADSCs have been observed in
ischemic models via promotion of angiogenesis by secretion
of angiogenic cytokines such as VEGF and hepatocyte
growth factor [39,40]. Therefore, after analysing the inflam-
matory cytokines, we decided to test for the secretion of
pro-angiogenic growth factors.
For this purpose, we chose PlGF, VEGF and TGF-β.
PlGF is a member of the VEGF family and both of these
growth factors are potent angiogenic factors along with
TGF-β, which is present in the initial stages of wound
healing and regulates inflammatory cellular responses.
hADSCs were seeded in P-SH-HA hydrogels at a density
of 0.5×106 cells/ml. Supernatant was collected at days 1,
3, 5 and 7 after seeding. Cells plated on TCP were also
used to analyse secretion. From the results it was noted
that production of PlGF increased in both conditions
(2D and 3D) over 7 days; however, there was significantly
more PlGF present in the 3D culture system (0 ng/ml atFigure 7 Secretion profile for growth factors of human adipose-deriv
Secretion profile of growth factors of human adipose-derived stem cells in
dimensional (3D)) and tissue culture plastic (two-dimensional (2D)) over 7 d
conditions in 48-well plates. Supernatant from both conditions was analyse
vascular endothelial growth factor (VEGF) and transforming growth factor bday 1 to 0.025 ± 0.01 ng/ml at day 7) at 7 days when com-
pared with day 1 (Figure 7). We also noted that VEGF
production is lower in 3D culture than in 2D culture over
all time points but the production of VEGF increased
(0.53 ± 0.05 ng/ml) over time from day 1 to day 7 (2.81 ±
0.25 ng/ml); a similar trend was noted in the media from
TCP seeded cells (Figure 7). TGF-β was also tested for
release and showed increased production over time in
both conditions (2D and 3D), but there was no significant
difference in concentration levels at any time for 3D
culture. These results suggest that hADSCs can secrete
growth factors, albeit at low levels. PlGF interestingly in-
creased over 7 days; however, the levels secreted were very
low. It is important to note that chemical and mechanical
properties of hydrogel can modulate the stem cell re-
sponse; therefore it is necessary to test different conditions
to optimise the production of pro-angiogenic growth fac-
tors. In conclusion, it can be observed that secretion and
maintenance of pro-angiogenic and anti-inflammatory cy-
tokines is possible in this P-SH-HA hydrogel system. The
next step is therefore optimising this hydrogel system to
increase the levels of secreted growth factors.ed stem cells in three-dimensional and two-dimensional culture.
both PEGMEMA–MEO2MA–PEGDA and HA hybrid hydrogel (three-
ays. Cells were seeded at 0.5×106 cells/ml in both 3D and 2D culture
d using a multiplex ELISA kit for placental-derived growth factor (PlGF),
eta (TGF-β) (n =3, P <0.05). *Statistical significance.
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This study shows that hADSCs can be successfully
encapsulated in a newly formed in situ P-SH-HA hydro-
gel system to support the maintenance of hADSCs and
to secrete essential growth factors. P-SH-HA hydrogel
does not induce cytotoxicity over a 7-day period as
measured by cell viability with live/dead staining and the
alamarBlueW assay. hADSCs successfully secreted pro-
angiogenic growth factors (PlGF, VEGF and TGF-β) and
did not induce toxicity or inflammatory response as
evident by low production of proinflammatory cytokines
(IFNγ and IL-2). This in situ thermoresponsive copolymer
with multiple acrylate groups has many advantages for the
potential applications in tissue engineering and wound
healing applications. The thermoresponsive property of this
hydrogel allows easy handling during clinical practice and
application as a dressing system. Furthermore, the multiple
acrylate groups within the copolymer can provide tune-
able mechanical properties leading to different swelling
properties, to release profiles of growth factors from the
gels and to allow control over secretion and cellular pro-
cesses. Taken together, these results indicate that the
PEG-HA-based synthetic extracellular matrix hydrogel
can be used for topical application to deliver cells for
wound healing applications.
Abbreviations
2D: Two-dimensional; 3D: Three-dimensional; ELISA: Enzyme-linked
immunosorbent assay; HA: Hyaluronic acid; HA-SH: Thiol-modified hyaluronic
acid; hADSC: Human adipose-derived stem cell; IFN: Interferon; IL: Interleukin;
MEO2MA: 2-(2-methoxyethoxy)ethyl methacrylate; NMR: Nuclear magnetic
resonance; P-SH-HA: PEGMEMA–MEO2MA–PEGDA and HA hybrid;
PBS: Phosphate-buffered saline; PEG: Polyethylene glycol; PEGDA: Poly
(ethylene glycol) Diacrylate; PEGMEMA: Poly(ethylene glycol) methyl ether
methylacrylate; PlGF: Placental-derived growth factor; RHAMM: Receptor for
hyaluronan-mediated motility; TCP: Tissue culture plastic; TGF-β: Transforming
growth factor beta; VEGF: Vascular endothelial growth factor.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
WW conceived the idea and designed the experiments, and WH and YD
executed all of the experiments. WH, YD and WW interpreted and analysed
the data and drafted the manuscript. WH was responsible for cell culture
experiments, collection and assembly of data. YD contributed to the
preparation of hydrogel materials. All authors read and approved the final
manuscript.
Acknowledgements
The Heath Research Board of Ireland and the Science Foundation Ireland
(SFI), the SFI Principal Investigator programme, DEBRA Ireland and DEBRA
Austria, and the National University of Ireland, Galway are gratefully
acknowledged for funding.
Received: 30 December 2012 Revised: 22 February 2013
Accepted: 14 March 2013 Published: 21 March 2013
References
1. Jones I, Currie L, Martin R: A guide to biological skin substitutes. Br J Plast
Surg 2002, 55:185–193.
2. Cha J, Falanga V: Stem cells in cutaneous wound healing. Clin Dermatol
2007, 25:73–78.3. Mimeault M, Hauke R, Batra SK: Stem cells: a revolution in therapeutics –
recent advances in stem cell biology and their therapeutic applications
in regenerative medicine and cancer therapies. Clin Pharmacol Ther 2007,
82:252–264.
4. Lau K, Paus R, Tiede S, Day P, Bayat A: Exploring the role of stem cells in
cutaneous wound healing. Exp Dermatol 2009, 18:921–933.
5. Falanga V, Schrayer D, Cha J, Butmarc J, Carson P, Roberts AB, Kim SJ:
Full-thickness wounding of the mouse tail as a model for delayed
wound healing: accelerated wound closure in Smad3 knock-out mice.
Wound Repair Regen 2004, 12:320–326.
6. Guo SD, Dipietro LA: Factors affecting wound healing. J Dent Res 2010,
89:219–229.
7. Werner S, Grose R: Regulation of wound healing by growth factors and
cytokines. Physiol Rev 2003, 83:835–870.
8. Nauta AJ, Fibbe WE: Immunomodulatory properties of mesenchymal
stromal cells. Blood 2007, 110:3499–3506.
9. Burdon TJ, Paul A, Noiseux N, Prakash S, Shum-Tim D: Bone marrow stem
cell derived paracrine factors for regenerative medicine: current
perspectives and therapeutic potential. Bone Marrow Res 2011, 2011:14.
Article ID 207326.
10. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz
HP, Hedrick MH: Multilineage cells from human adipose tissue:
implications for cell-based therapies. Tissue Eng 2001, 7:211–228.
11. Schäffler A, Büchler C: Concise review: adipose tissue-derived stromal
cells–basic and clinical implications for novel cell-based therapies.
Stem Cells 2007, 25:818–827.
12. Kim WS, Park BS, Sung JH: The wound-healing and antioxidant effects of
adipose-derived stem cells. Expert Opin Biol Ther 2009, 9:879–887.
13. Ebrahimian TG, Pouzoulet F, Squiban C, Burad V, André M, Cousion B,
Gourmelon P, Benderitter M, Casteilla L, Tamarat R: Cell therapy based on
adipose tissue-derived stromal cells promote physiological and
pathological wound healing. Arteriosclerosis, Thrombosis, and Vascular
biology 2009, 29:503–510
14. Kim WS, Park BS, Sung JH, Yang JM, Park SB, Kwak SJ, Park JS: Wound
healing effect of adipose-derived stem cells: a critical role of secretory
factors on human dermal fibroblasts. J Dermatol Sci 2007, 48:15–24.
15. Wu KH, Mo XM, Han ZC, Zhaou B: Stem cell engraftment and survival in
the ischemic heart. Ann Thorac Surg 2011, 92:1917–1925.
16. Lee K, Silva EA, Mooney DJ: Growth factor delivery-based tissue
engineering: general approaches and a review of recent developments.
J R Soc Interface 2011, 8:153–170.
17. Prestwich GD, Shu XZ, Liu Y, Cai S, Walsh JF, Hughes CW, Ahmad S, Kirker
KR, Yu B, Orlandi RR, Park AH, Thibeault SL, Duflo S, Smith ME: Injectable
synthetic extracellular matrices for tissue engineering and repair tissue
engineering. Adv Exp Med Biol 2006, 585:125–133.
18. Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA:
Hydrogels in regenerative medicine. Adv Mater 2009, 21:3307–3329.
19. Drury JL, Mooney DJ: Hydrogels for tissue engineering: scaffold design
variables and applications. Biomaterials 2003, 24:4337–4351.
20. Brandl F, Sommer F, Goepferich A: Rational design of hydrogels for tissue
engineering: impact of physical factors on cell behavior.
Biomaterials 2007, 28:134–146.
21. Pang Y, Liu J, Wu J, Li G, Wang R, Su Y, He P, Zhu X, Yan D, Zhu B:
Synthesis, characterization, and in vitro evaluation of long-chain
hyperbranched poly(ethylene glycol) as drug carrier. Bioconjug Chem
2010, 21:2093–2102.
22. Lutolf MP, Hubbell JA: Synthetic biomaterials as instructive extracellular
microenvironments for morphogenesis in tissue engineering.
Nat Biotechnol 2005, 23:47–55.
23. Burdick JA, Vunjak-Novakovic G: Engineered microenvironments for
controlled stem cell differentiation. Tissue Eng Part A 2009, 15:205–219.
24. Nicodemus GD, Bryant SJ: Cell encapsulation in biodegradable hydrogels
for tissue engineering applications. Tissue Eng Part B Rev 2008, 14:149–165.
25. Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak-Novakovic
G: Hyaluronic acid hydrogel for controlled self-renewal and
differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A
2007, 104:11298–11303.
26. Burdick JA, Prestwich GD: Hyaluronic acid hydrogels for biomedical
applications. Adv Mater 2011, 23:H41–H56.
27. Dong Y, Hassan W, Zheng Y, Saeed AO, Cao H, Tai H, Pandit A, Wang W:
Thermoresponsive hyperbranched copolymer with multi acrylate
Hassan et al. Stem Cell Research & Therapy 2013, 4:32 Page 11 of 11
http://stemcellres.com/content/4/2/32functionality for in situ cross-linkable hyaluronic acid composite
semi-IPN hydrogel. J Mater Sci Mater Med 2012, 23:25–35.
28. Dong Y, Saeed AO, Hassan W, Keigher C, Zheng Y, Tai H, Pandit A, Wang W:
‘One-step’ Preparation of thiol-ene clickable PEG-based
thermoresponsive hyperbranched copolymer for in situ crosslinking
hybrid hydrogel. Macromol Rapid Commun 2012, 33:120–126.
29. Chicurel ME, Chen CS, Ingber DE: Cellular control lies in the balance of
forces. Curr Opin Cell Biol 1998, 10:232–239.
30. Hachet E, Van Den Berghe H, Bayma E, Block MR, Auzély-Velty R: Design of
biomimetic cell-interactive substrates using hyaluronic acid hydrogels with
tunable mechanical properties. Biomacromolecules 2012, 13:1818–1827.
31. Lei Y, Gojgini S, Lam J, Segura T: The spreading, migration and
proliferation of mouse mesenchymal stem cells cultured inside
hyaluronic acid hydrogels. Biomaterials 2011, 32:39–47.
32. Chen X, Thibeault SL: Biocompatibility of a synthetic extracellular matrix
on immortalized vocal fold fibroblasts in 3-D culture. Acta Biomater 2010,
6:2940–2948.
33. Lao G, Yan L, Yang C, Zhang L, Zhang S, Zhou Y: Controlled release of
epidermal growth factor from hydrogels accelerates wound healing in
diabetic rats. J Am Podiatr Med Assoc 2012, 102:89–98.
34. Peattie RA, Rieke ER, Hewett EM, Fisher RJ, Shu XZ, Prestwich GD: Dual
growth factor-induced angiogenesis in vivo using hyaluronan hydrogel
implants. Biomaterials 2006, 27:1868–1875.
35. Liu Y, Cai S, Shu XZ, Shelby J, Prestwich GD: Release of basic fibroblast
growth factor from a crosslinked glycosaminoglycan hydrogel promotes
wound healing. Wound Repair Regen 2007, 15:245–251.
36. Alfano C, Angelisanti M, Calzoni C, Somma F, Chiummariello S: Treatment
of ulcer and difficult wounds of the lower limbs: our experience. Ann Ital
Chir 2012, 83:135–141.
37. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah
PK, Willerson JT, Benza RL, Berman DS, Gibson CM, Bajamonde A, Rundle
AC, Fine J, Mc Cluskey ER, VIVA Investigators: The VIVA trial, vascular
endothelial growth factor in ischemia for vascular angiogenesis.
Circulation 2003, 107:1359–1365.
38. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, Isner JM:
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor
via induction of vascular endothelial growth factor: the case for
paracrine amplification of angiogenesis. Circulation 1998, 97:381–390.
39. Miranville A, Heeschen C, Sengenès C, Curat CA, Busse R, Bouloumié A:
Improvement of postnatal neovascularization by human adipose tissue-
derived stem cells. Circulation 2004, 110:349–355.
40. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE,
Pell CL, Johnstone BH, Considine RV, March KL: Secretion of angiogenic
and antiapoptotic factors by human adipose stromal cells.
Circulation 2004, 109:1292–1298.
doi:10.1186/scrt182
Cite this article as: Hassan et al.: Encapsulation and 3D culture of
human adipose-derived stem cells in an in-situ crosslinked hybrid
hydrogel composed of PEG-based hyperbranched copolymer and
hyaluronic acid. Stem Cell Research & Therapy 2013 4:32.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
